Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Cancer Res. 2009 Jan 1;69(1):37–44. doi: 10.1158/0008-5472.CAN-08-1648

Figure 2. TGFBI−/− mice showed an increased tumor incidence.

Figure 2

(A) Images of Low grade lymphoma in Live (left panel) and Lung (right panel). (B) Image of metastasized tumor in liver (left panel) and lung adenocarcinoma (right panel). Magnification of images (A–B): ×400. (C) Tumor-free survival of TGFBI−/− mice compared with wild type and heterozygots. (D) Incidence of DMBA-induced skin tumors in wild type and TGFBI−/− mice.